venlafaxine
- Product NDC
- 52427-632
- 11-digit product format
- 524270632
- Labeler code
- 52427
- Product ID
- 52427-632_e80091b4-ac1f-a50e-8ba3-54c794794928
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- venlafaxine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Almatica Pharma LLC
- Application
- NDA215429
- Marketing category
- NDA
- Marketing start
- 2022-06-30
- Substance
- VENLAFAXINE BESYLATE MONOHYDRATE
- Active strength
- 112.5 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N215429-001 | VENLAFAXINE BESYLATE | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N215429-001 | VENLAFAXINE BESYLATE | EQ 112.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-29 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N215429-001 | 6717015 | 2023-03-27 | U-451 | Drug substance, Drug product | 2022-07-20 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | e64feba35796… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N215429-001 | 7776358 | 2028-05-16 | Drug product | 2022-07-20 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- venlafaxine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| VENLAFAXINE BESYLATE MONOHYDRATE | 112.5 mg/1 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 17db3736-056c-48b9-b0f4-00fccabb14e6 | Product name | 5 | 20251118 |
| 7be8b949-f2c0-bdd8-e89d-8af92c1b2ead | Product name | 9 | 20250224 |
| b1435b59-059c-404b-a587-53656bf80e17 | Product name | 1 | 20230314 |
| 6005cd75-f7b1-d6be-3cb5-4bd30d5c4617 | Product name | 3 | 20190314 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52427-632-30 | venlafaxine | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52427-632-30 | EA - Each | 52427-632 | 49d4e14b-5e36-479a-beeb-095e31d52147 | 1 | 2022-08-04 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2605950 | venlafaxine 112.5 MG 24HR Extended Release Oral Tablet | PSN | e81a2daf-b8b2-7c05-b532-bc775700b100 | 4 |
| 2605950 | 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet | SCD | e81a2daf-b8b2-7c05-b532-bc775700b100 | 4 |
| 2605950 | venlafaxine 112.5 MG (as venlafaxine besylate monohydrate 183.95 MG) 24 HR Extended Release Oral Tablet | SY | e81a2daf-b8b2-7c05-b532-bc775700b100 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 52427-632-30 | 52427063230 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (52427-632-30) | 2022-08-01 | 0000-00-00 | No | No | Current |